Peripheral Blood Haplo-SCT Feasible for Leukemia Patients 70 Years and Older
Drugs.com - Acute Myeloid Leukemia News
by
3M ago
WEDNESDAY, Dec. 20, 2023 – For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a ..read more
Visit website
Allogeneic HCT After Primary Induction Failure Beneficial in Leukemia
Drugs.com - Acute Myeloid Leukemia News
by
3M ago
THURSDAY, Dec. 21, 2023 – For patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term ..read more
Visit website
Fewer Complications Seen With Vitamin C, D Supplementation in AML
Drugs.com - Acute Myeloid Leukemia News
by
7M ago
WEDNESDAY, Sept. 6, 2023 – For patients with acute myeloid leukemia (AML), supplementation with vitamins C and D during chemotherapy may improve outcomes but may not improve overall survival (OS ..read more
Visit website
Precursor to Blood Cancer Is 'Tricky to Diagnose,' Study Shows
Drugs.com - Acute Myeloid Leukemia News
by
8M ago
WEDNESDAY, Aug. 9, 2023 – New research shows hard-to-diagnose blood disorders called myelodysplastic syndromes/neoplasms (MDS) are often misdiagnosed and a second opinion may be needed. The ..read more
Visit website
Spleen Volume Linked to Outcome After HSCT for Leukemia Patients
Drugs.com - Acute Myeloid Leukemia News
by
9M ago
WEDNESDAY, July 19, 2023 – For patients with acute myeloid leukemia (AML), higher spleen volume at the time of hematopoietic stem cell transplant (HSCT) is associated with inferior overall survival ..read more
Visit website
FDA Approves Vanflyta (quizartinib) for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia
Drugs.com - Acute Myeloid Leukemia News
by
9M ago
TOKYO & BASKING RIDGE, N.J. July 20, 2023 --(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) today announced that Vanflyta (quizartinib) has been approved by the U.S. Food and Drug Administration (FDA) in ..read more
Visit website
Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
Drugs.com - Acute Myeloid Leukemia News
by
1y ago
TUESDAY, Feb. 21, 2023 – In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be ..read more
Visit website
Survival Lower for Children With Leukemia Living on Texas-Mexico Border
Drugs.com - Acute Myeloid Leukemia News
by
1y ago
TUESDAY, Feb. 21, 2023 – For children with acute lymphoblastic leukemia (ALL), but not those with acute myeloid leukemia (AML), living along the Texas-Mexico border is associated with inferior ..read more
Visit website
FDA Approves Rezlidhia (olutasidenib) for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation
Drugs.com - Acute Myeloid Leukemia News
by
1y ago
Rezlidhia is a potentially market-leading, oral, mutant isocitrate dehydrogenase-1 (mIDH1) inhibitor Phase 2 registrational data supporting the approval showed a 35% CR+CRh rate in mIDH1 R/R AML ..read more
Visit website
Cesarean Section Tied to Higher Risk for Later Leukemia in Offspring
Drugs.com - Acute Myeloid Leukemia News
by
1y ago
THURSDAY, Sept. 15, 2022 – Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 ..read more
Visit website

Follow Drugs.com - Acute Myeloid Leukemia News on FeedSpot

Continue with Google
Continue with Apple
OR